{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:01:44Z","timestamp":1780340504365,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcmd.2026.103007","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:10:56Z","timestamp":1777590656000},"page":"103007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia"],"prefix":"10.1016","volume":"119","author":[{"given":"Bita","family":"Asghariastanehei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Connes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Carin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ducray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Poutrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Halfon-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcmd.2026.103007_bb0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.103007_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcmd.2026.103007_bb0015","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.htct.2024.09.051","article-title":"Preliminary results from a multicenter phase 2\/3 study of next-generation sickle hemoglobin polymerization inhibitor osivelotor (GBT021601) for the treatment of patients with sickle cell disease","volume":"46","author":"Saraf","year":"2024","journal-title":"Hematol. Transfusion Cell Ther."},{"key":"10.1016\/j.bcmd.2026.103007_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.551441","article-title":"Association between nitric oxide, oxidative stress, eryptosis, red blood cell microparticles, and vascular function in sickle cell anemia","volume":"11","author":"Nader","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcmd.2026.103007_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biom11070963","article-title":"Ex vivo activation of red blood cell senescence by plasma from sickle-cell disease patients: correlation between markers and adhesion consequences during acute disease events","volume":"11","author":"Chadebech","year":"2021","journal-title":"Biomolecules"},{"issue":"2\u20133","key":"10.1016\/j.bcmd.2026.103007_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/CH-189007","article-title":"Sickle cell dehydration: pathophysiology and therapeutic applications","volume":"68","author":"Brugnara","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"3","key":"10.1016\/j.bcmd.2026.103007_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/bjh.18799","article-title":"Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner","volume":"202","author":"Nader","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2026.103007_bb0040","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.12786","article-title":"Haemolysis and abnormal haemorheology in sickle cell anaemia","volume":"165","author":"Connes","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2026.103007_bb0045","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcmd.2026.103007_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2015.08.005","article-title":"The role of blood rheology in sickle cell disease","volume":"30","author":"Connes","year":"2016","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.bcmd.2026.103007_bb0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/bjh.15686","article-title":"New insights into red cell rheology and adhesion in patients with sickle cell anaemia during vaso-occlusive crises","volume":"185","author":"Lapoumeroulie","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.bcmd.2026.103007_bb0060","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3324\/haematol.2012.066670","article-title":"Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease","volume":"97","author":"Lamarre","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bcmd.2026.103007_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/bjh.12912","article-title":"Effects of oxidative stress on red blood cell rheology in sickle cell patients","volume":"166","author":"Hierso","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.103007_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01329","article-title":"Blood rheology: key parameters, impact on blood flow, role in sickle cell disease and effects of exercise","volume":"10","author":"Nader","year":"2019","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103007_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/CH-170340","article-title":"GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions","volume":"70","author":"Dufu","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103007_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jha2.831","article-title":"Voxelotor improves red blood cell functionality in children with sickle cell anaemia: an ancillary study of the HOPE-KIDS 1 trial","volume":"5","author":"Chonat","year":"2024","journal-title":"EJHaem"},{"issue":"6","key":"10.1016\/j.bcmd.2026.103007_bb0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/bcp.13896","article-title":"Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease","volume":"85","author":"Hutchaleelaha","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"26","key":"10.1016\/j.bcmd.2026.103007_bb0090","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103007_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CH-2009-1202","article-title":"New guidelines for hemorheological laboratory techniques","volume":"42","author":"Baskurt","year":"2009","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.bcmd.2026.103007_bb0100","doi-asserted-by":"crossref","DOI":"10.3791\/60213","article-title":"Characterization of sickling during controlled automated deoxygenation with oxygen gradient ektacytometry","author":"Rab","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.bcmd.2026.103007_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjh.14214","article-title":"GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease","volume":"175","author":"Oksenberg","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.bcmd.2026.103007_bb0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.25443","article-title":"Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients","volume":"94","author":"Rab","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.bcmd.2026.103007_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158182","article-title":"Effect of age on blood rheology in sickle cell anaemia and sickle cell haemoglobin C disease: a cross-sectional study","volume":"11","author":"Renoux","year":"2016","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2026.103007_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/CH-238122","article-title":"Blood rheology and vascular function in sickle cell trait and sickle cell disease: from pathophysiological mechanisms to clinical usefulness","volume":"86","author":"Connes","year":"2024","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.bcmd.2026.103007_bb0125","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.3324\/haematol.2015.130435","article-title":"Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia","volume":"100","author":"Lemonne","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bcmd.2026.103007_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43200-y","article-title":"Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic condition","volume":"9","author":"Renoux","year":"2019","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.bcmd.2026.103007_bb0135","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood-2017-04-590810","article-title":"Disorders of erythrocyte hydration","volume":"130","author":"Gallagher","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2026.103007_bb0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI109888","article-title":"Analysis of factors regulating erythrocyte deformability","volume":"66","author":"Mohandas","year":"1980","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bcmd.2026.103007_bb0145","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1159\/000447895","article-title":"A comprehensive review on eryptosis","volume":"39","author":"Pretorius","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.bcmd.2026.103007_bb0150","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1021\/acs.jafc.2c00269","article-title":"5-Hydroxymethylfurfural exerts negative effects on gastric mucosal epithelial cells by inducing oxidative stress, apoptosis, and tight junction disruption","volume":"70","author":"Qiu","year":"2022","journal-title":"J. Agric. Food Chem."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:08:06Z","timestamp":1780337286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S1079979626000306"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103007"}}